| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.065 | 0.2 |